JMT103

TERMINATED · PHASE1, PHASE2 · Hypercalcemia of Malignancy

Due to a change in the company's research strategy

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.